Home By PE Sector Buyout TPG shifts Aptalis exit strategy to IPO following failed $3bn-plus sale process

TPG shifts Aptalis exit strategy to IPO following failed $3bn-plus sale process

By

-

October 24, 2013

569

TPG Capital-backed drugmaker Aptalis Pharma has reportedly hired underwriters for an IPO of the business after its plans

Technology partner